Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Berne's Whole Health Products marketed over-the-counter, non-pharmaceutical eye care and supplement products, notably MSM-based eye drops, castor oil eye drops, and eye health supplements. The company voluntarily recalled its key ophthalmic products in August 2023 after FDA found bacterial and fungal contamination in MSM eye drops. No clinical efficacy trials have been conducted; claims are based on user testimonials and holistic self-care methods. Two adverse events have been reported following contaminated eye drop use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. Berne's Whole Health Products.